Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 43 out of 100. Tau biomarkers

Topic: Brain proteins, microglia and lab models

Late-onset Alzheimer disease (LOAD), the most common form of dementia among older adults, is a neurodegenerative disease characterized by brain amyloid-β (Aβ) plaque deposition and neurofibrillary tangles. The causes of LOAD are not known but several recent lines of evidence implicate the adaptive immune system. Here, we sought to characterize somatic T-cell receptor (TCR) sequence diversity profiles and class I and II human leukocyte antigen (HLA) alleles from DNA extracted from peripheral tissues from Midwestern Amish participating in longitudinal studies of aging.

Key findings

Why it matters

This study characterized T-cell receptor sequence diversity and HLA alleles from peripheral tissue DNA of 72 Midwestern Amish participants in longitudinal aging studies, based on evidence implicating the adaptive immune system in late-onset Alzheimer's disease. It is an early immune-focused investigation and does not establish a treatment, cure, or prevention.

Study details

How this study scored 43/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year left out, no data; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 3 of 4; Institution's track record 1 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 1 of 2; Free to read 0 of 2. 40 of the 94 points it could be judged on, which is 43 of 100. Total 43 of 100.40 of the 94 points we could judge = 43 of 100

Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on impact for its field and year, so that was left out: it earned 40 of the 94 points we could judge it on, which is 43 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Annals of human genetics)
Journal's citation record 1 / 4 Annals of Human Genetics: journal h-index 132 (OpenAlex, 2026-10-29)
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Dana C. Crawford: h-index 65 (OpenAlex, whole career)
Institution's track record 1 / 3 Case Western Reserve University: institution h-index 1,159 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 6 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Points 40 / 94 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 40 of the 94 points we could judge it on is 43 out of 100.
Total 43 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

APA 7th

Cruz, L. A., Liu, S., Miskimen, K. L., Cooke Bailey, J. N., Kinzy, T., Song, Y. E., et al. (2026). Evidence for reduced somatic T-cell receptor sequence diversity profiles among Midwestern Amish in an aging cohort study. Annals of human genetics. https://doi.org/10.64898/2026.01.25.26344754

Vancouver

Cruz LA, Liu S, Miskimen KL, Cooke Bailey JN, Kinzy T, Song YE, et al. Evidence for reduced somatic T-cell receptor sequence diversity profiles among Midwestern Amish in an aging cohort study. Annals of human genetics. 2026. doi:10.64898/2026.01.25.26344754.

BibTeX

@article{cruz2026-7762a1d1,
  author  = {Cruz, L. A. and Liu, S. and Miskimen, K. L. and Cooke Bailey, J. N. and Kinzy, T. and Song, Y. E. and Laux, R. A. and Miron, P. and others},
  title   = {{Evidence for reduced somatic T-cell receptor sequence diversity profiles among Midwestern Amish in an aging cohort study}},
  journal = {Annals of human genetics},
  year    = {2026},
  doi     = {10.64898/2026.01.25.26344754},
  url     = {https://doi.org/10.64898/2026.01.25.26344754}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 20.

Related studies in Tau biomarkers

Also tagged “amyloid-beta”

1,339 studies in the library carry the topic tag “amyloid-beta”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,339 tagged studies.

Similar studies

More on Tau biomarkers

See all studies in Tau biomarkers →